MD

Nanofabricated Matrix for the Treatment of Surgical Wounds

Nanofiber matrix* is a product that offers a novel approach to second intention healing after skin cancer or vascular surgery. Secondary intention healing is often chosen for wounds in mi...

01/28/2021

Multifaceted Targeted Nutrient Strategy Successfully Utilized To Reverse Grade 3-4 Radiation Dermatitis

This case describes a 65 year-old with T3N0M0 anal squamous cell cancer, treated with 5 weeks of capecitabine and mitomcyin chemoradiation, referred to wound care for persistent grade 3-4...

01/28/2021

Esterified Hyaluronic Acid Matrix* Treatment after Surgical Excision in Patients with Refractory Hidradenitis Suppurativa Promotes Healing and is Associated with Less Post-Operative Pain.

Introduction:Hidradenitis Suppurativa (HS) is a poorly understood disease that afflicts approximately 8.6 per 100,000 people a year in the US.1 Surgical excision of the infected skin and...

01/28/2021

COVID-19 bullae/wounds

On March 11, 2020, the World Health Organization declared that COVID-19 met the definition of a pandemic. On that day, there were 3 COVID-19 patients hospitalized within our medical cent...

01/28/2021

Dehydrated Human Amnion Chorion Membrane (dHACM)* Allograft Utilization in the Revision and Closure of an Infected Ruptured Arteriovenous (AV) Fistula

We present our experience using dehydrated human amnion/chorion membrane (dHACM) allograft as a novel adjunct therapy integrated into the treatment plan and restoration of a failed arteri...

01/28/2021

Use of a Purified Reconstituted Bilayer Matrix in the Management of Non-Healing Diabetic Foot Ulcers: A Prospective Randomized Controlled Multicenter Clinical Trial

Patients with diabetic foot ulcers (DFUs), in particular when unresponsive to standard wound care, face serious risks of severe complications, including infection and amputation. The mana...

01/28/2021

The effect of frailty on management of diabetic foot ulcers: Comparative effectiveness of two matrices products – a randomized controlled trial

This randomized controlled trial examined the effect of frailty on success of wound granulation with a human acellular dermal matrix (DM)* and a bilayer bovine dermal matrix (BLM). ...

01/28/2021

The use of Point-of-Care Bacterial Autofluorescence Imaging in the Management of Diabetic Foot Ulcers: A Pilot Randomised Controlled Trial

This is a single centre, pilot randomised controlled trial (RCT) in patients with a DFU, with blinded outcome assessment. Patients were randomised in a 1:1 allocation ratio to either tre...

01/28/2021

Effectiveness of Continuous Diffusion of Oxygen Adjunct Therapy to Improve Success Rate of Lower Extremity Surgically Closed Wounds – A Randomized Controlled Trial Study

Lower-extremity surgically closed wounds in patients with diabetes could be severely affected by poor tissue oxygenation (1-2). Adverse events (AE) such as necrosis, dehiscence, or re-ope...

01/28/2021

Dehydrated placental allograft (DPA) for the management of diabetic foot ulcers – a randomized controlled trial

Diabetic foot ulcers (DFUs) continue to challenge wound care practitioners. They are prone to infection and increase the risk of lower extremity amputation. The aim of this study was to e...

01/28/2021